Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Lynn Wang

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Molecular Diagnostics : JMD|February 28, 2018
MYD88 Mutations and Sensitivity to Ibrutinib TherapyY Lynn Wang
The Journal of Molecular Diagnostics : JMD|July 24, 2013
Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitationChaoJie Zhen, Y Lynn Wang
The Journal of Molecular Diagnostics : JMD|July 3, 2020
Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic LeukemiaJimmy Lee, Y Lynn Wang
PPAR Research|September 12, 2008
To Live or to Die: Prosurvival Activity of PPARgamma in CancersY Lynn Wang, Qi Miao
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2011
Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitionersLuke P Akard, Y Lynn Wang
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2013
Molecular and immunohistochemical detection of Kaposi sarcoma herpesvirus/human herpesvirus-8Amy Chadburn, Janet Wilson, Y Lynn Wang
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 17, 2005
Detection of BCL2-IGH using single-round PCR assaysMario Gomez, Xuemei Wu, Y Lynn Wang
JAMA Oncology|October 9, 2015
Prognosis in Chronic Lymphocytic Leukemia-ReplyChadi Nabhan, Gordana Raca, Y Lynn Wang
JAMA Oncology|July 17, 2015
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary EraChadi Nabhan, Gordana Raca, Y Lynn Wang
British Journal of Haematology|August 27, 2022
Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphomaShazia Nakhoda, Aldana Vistarop, Y Lynn Wang
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Molecular Diagnostics : JMD|February 28, 2018
MYD88 Mutations and Sensitivity to Ibrutinib TherapyY Lynn Wang
The Journal of Molecular Diagnostics : JMD|July 24, 2013
Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitationChaoJie Zhen, Y Lynn Wang
The Journal of Molecular Diagnostics : JMD|July 3, 2020
Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic LeukemiaJimmy Lee, Y Lynn Wang
PPAR Research|September 12, 2008
To Live or to Die: Prosurvival Activity of PPARgamma in CancersY Lynn Wang, Qi Miao
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2011
Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitionersLuke P Akard, Y Lynn Wang
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2013
Molecular and immunohistochemical detection of Kaposi sarcoma herpesvirus/human herpesvirus-8Amy Chadburn, Janet Wilson, Y Lynn Wang
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 17, 2005
Detection of BCL2-IGH using single-round PCR assaysMario Gomez, Xuemei Wu, Y Lynn Wang
JAMA Oncology|October 9, 2015
Prognosis in Chronic Lymphocytic Leukemia-ReplyChadi Nabhan, Gordana Raca, Y Lynn Wang
JAMA Oncology|July 17, 2015
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary EraChadi Nabhan, Gordana Raca, Y Lynn Wang
British Journal of Haematology|August 27, 2022
Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphomaShazia Nakhoda, Aldana Vistarop, Y Lynn Wang
Pageof 7